Situation
A biopharmaceutical company developing innovative therapies for people with rare debilitating diseases sought to accelerate trial enrollment.
The Approach
- Designed and implemented a compliant patient lead generation program targeting full enrollment
- Directed patients to a clinical trial website with a digital prescreener
- Gave authorized clinical trial personnel secure access to patient screening and enrollment data via the Adnexi Portal
Results
82
Patients completed pre-screen
46
Patients completed screening at an active site
22
Patients randomized in 12 months (~30% of trial)